Search Results - "Calabresi, F"

Changes in colonic contractility in response to inflammatory bowel disease: Long-term assessment in a model of TNBS-induced inflammation in rats by Calabresi, Marcos F.F., Tanimoto, Alexandre, Próspero, André G., Mello, Fabio P.F., Soares, Guilherme, Di Stasi, Luiz C., Miranda, José R.A.

“…Inflammatory bowel disease is a chronic relapsing inflammation that affects the gastrointestinal tract, causing changes in colonic motility. The evolution of…”
Get full text

Alternate current biosusceptometry for the assessment of gastric motility after proximal gastrectomy in rats: a feasibility study by Calabresi, M. F. F., Quini, C. C., Matos, J. F., Moretto, G. M., Americo, M. F., Graça, J. R. V., Santos, A. A., Oliveira, R. B., Pina, D. R., Miranda, J. R. A.

“…Background This study proposes an experimental model to assess the consequences of gastric surgeries on gastric motility. We investigated the effects of…”
Get full text

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study by Pollera, C F, Ceribelli, A, Crecco, M, Calabresi, F

“…Gemcitabine (2'2-difluorodeoxycytidine; GEM) is a novel deoxycytidine analogue with promising antitumor activity, currently under phase II investigation at…”
Get more information

Real-time liver uptake and biodistribution of magnetic nanoparticles determined by AC biosusceptometry by Quini, Caio C, Próspero, André G, Calabresi, Marcos F.F, Moretto, Gustavo M, Zufelato, Nicholas, Krishnan, Sunil, Pina, Diana R, Oliveira, Ricardo B, Baffa, Oswaldo, Bakuzis, Andris F, Miranda, Jose R.A

“…Abstract We describe the development of a joint in vivo/ex vivo protocol to monitor magnetic nanoparticles in animal models. Alternating current…”
Get full text

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study by Martelli, M, Vignetti, M, Zinzani, P L, Gherlinzoni, F, Meloni, G, Fiacchini, M, De Sanctis, V, Papa, G, Martelli, M F, Calabresi, F, Tura, S, Mandelli, F

“…To evaluate, in a prospective multicentric study, the efficacy of a conventional salvage chemotherapy (dexamethasone, cisplatin, and cytarabine [DHAP]) versus…”
Get more information

Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometry by Próspero, André G, Quini, Caio C, Bakuzis, Andris F, Fidelis-de-Oliveira, Patrícia, Moretto, Gustavo M, Mello, Fábio P F, Calabresi, Marcos F F, Matos, Ronaldo V R, Zandoná, Ednaldo A, Zufelato, Nícholas, Oliveira, Ricardo B, Miranda, José R A

“…We introduce and demonstrate that the AC biosusceptometry (ACB) technique enables real-time monitoring of magnetic nanoparticles (MNPs) in the bloodstream. We…”
Get full text

Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer by Pérez Carrión, R, Alberola Candel, V, Calabresi, F, Michel, R T, Santos, R, Delozier, T, Goss, P, Mauriac, L, Feuilhade, F, Freue, M

“…A total of 409 postmenopausal patients with advanced metastatic breast cancer were randomized to receive either formestane (Lentaron) 250 mg every 2 weeks by…”
Get more information

Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial by Conte, P F, Giannessi, P G, Latreille, J, Mauriac, L, Koliren, L, Calabresi, F, Ford, J M

“…A total of 295 patients with lytic bone metastases from breast cancer were randomized to receive chemotherapy or chemotherapy plus pamidronate (Aredia) 45 mg…”
Get more information

Biological response modifiers by Calabresi, F., Gamucci, T.

“…Biological response modifiers (BRMs) of current clinical interest may be divided into two categories: immunomodulating agents and colony stimulating factors…”
Get full text

Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer by Cognetti, F, Pinnarö, P, Ruggeri, E M, Carlini, P, Perrino, A, Impiombato, F A, Calabresi, F, Chilelli, M G, Giannarelli, D

“…Between May 1981 and December 1987, 152 consecutive patients with locally advanced and previously untreated head and neck squamous cell cancer (HNSCC) received…”
Get more information

Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment by Boccoli, G, Masciulli, R, Ruggeri, E M, Carlini, P, Giannella, G, Montesoro, E, Mastroberardino, G, Isacchi, G, Testa, U, Calabresi, F

“…Serum concentration kinetics of gamma-interferon (IFN-gamma), neopterin, 2'-5' A synthetase and tumor necrosis factor alpha were determined in five cancer…”
Get full text

Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9 by Schellens, J HM, Dombernowsky, P, Cassidy, J, Epelbaum, R, Dirix, L, Cox, E H, Wanders, J, Calabresi, F, Paridaens, R, Monfardini, S, Wolff, J, Loos, W J, Verweij, J, Pavlidis, N, Hanauske, A-R

“…Population pharmacokinetic-dynamic analysis was prospectively integrated in the clinical phase II programme of EO9 to determine the population pharmacokinetic…”
Get full text

Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats by Quini, Caio C, Américo, Madileine F, Corá, Luciana A, Calabresi, Marcos Ff, Alvarez, Matheus, Oliveira, Ricardo B, Miranda, Jose Ricardo A

“…AC Biosusceptometry (ACB) was previously employed towards recording gastrointestinal motility. Our data show a reliable and successful evaluation of…”
Get full text

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study by Nardi, M, Cognetti, F, Pollera, C F, Giulia, M D, Lombardi, A, Atlante, G, Calabresi, F

“…A phase II study was initiated in March 1987 at the Regina Elena National Cancer Institute of Rome to evaluate the efficacy of alternating intraperitoneal (IP)…”
Get more information

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial by Ambrosini, G, Balli, M, Garusi, G, Demicheli, R, Jirillo, A, Bonciarelli, G, Bruscagnin, G, Fila, G, Bumma, C, Lacroix, F, Buzzi, F, Di Costanzo, F, Padalino, D, Brugia, M, Calabresi, F, Natali, M, Cartei, G, Chiesa, G, Blasina, B, Ciambellotti, E, Moro, G, D'Aquino, S, Altavilla, G, Adamo, V, De Maria, D, Falchi, A M, Bertoncelli, P, Farris, A, Fiorentino, M, Fornasiero, A, Fosser, V, Daniele, O, Foggi, C M, Speranza, G B, Sartori, S, Camilluzzi, E, Gallo, L, Poggio, R, Secondo, V, Gambi, A, Grignani, F, Capodicasa, E, Lopez, M, Papaldo, P, Di Lauro, L, Vici, P, Marenco, G, Folco, U, Bonanni, F, Marsilio, P, Palazzotto, G, Di Carlo, A, Cusimano, M P, Pastorino, G, Puccetti, C, Giusto, M, Rausa, L, Gebbia, N, Palmeri, S, D'Alessandro, N, Saccani, F, Becchi, G, Schieppati, G, Spinelli, I, Tagliagambe, A, Tonato, M, Minotti, V, Ardia, A, Viaro, D, De Micheli, P, Zingali, G, Sacchetti, G, Intini, C

“…From February 1983 to January 1985, 497 patients with advanced breast cancer were randomly allocated to receive either epirubicin or doxorubicin in the…”
Get more information

Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma by Calabresi, F, Aapro, M, Becquart, D, Dirix, L, Wils, J, Ardizzoni, A, Gerard, B

Get more information

Renal perfusion evaluation by alternating current biosusceptometry of magnetic nanoparticles by Quini, Caio C., Matos, Juliana F., Próspero, André G., Calabresi, Marcos Felipe F., Zufelato, Nicholas, Bakuzis, Andris F., Baffa, Oswaldo, Miranda, José Ricardo A.

“…Alternating current susceptometry, a simple and affordable technique, was employed to study the sensitivity of this approach to assess rat kidney perfusion by…”
Get full text

Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin by Gamucci, T, Thorel, M F, Frasca, A M, Giannarell, D, Calabresi, F

Get more information

Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study by Falcone, A, Pfanner, E, Ricci, S, Bertuccelli, M, Cianci, C, Carrai, M, De Marco, S, Ceribelli, A, Barduagni, M, Calabresi, F

“…Cancer chemotherapy in elderly patients is an important and under-researched area. Doxifluridine is a fluoropyrimidine derivative and is activated to…”
Get more information

Final report of a phase II study of interleukin 2 and interferon α in patients with metastatic melanoma by KRUIT, W. H. J, GOEY, S. H, CALABRESI, F, LINDEMANN, A, STAHEL, R. A, POLIWODA, H, OSTERWALDER, B, STOTER, G

“…Fifty-seven patients with metastatic melanoma were treated with interleukin 2 (IL-2) 7.8 MIU m-2 day-1 as a continuous infusion for 4 days combined with…”
Get full text